『Alcon Gains FDA Approval for Novel DED Drug』のカバーアート

Alcon Gains FDA Approval for Novel DED Drug

Alcon Gains FDA Approval for Novel DED Drug

無料で聴く

ポッドキャストの詳細を見る

このコンテンツについて

Alcon receives FDA approval for a novel pharmaceutical treatment for dry eye disease; Genentech’s Susvimo ocular implant is approval for a third indication in the US; and the makers of two investigational treatments for wet AMD complete enrollment in their respective phase 3 trials. Learn more about your ad choices. Visit megaphone.fm/adchoices

Alcon Gains FDA Approval for Novel DED Drugに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。